In this issue:
PRAISE-U aims to reduce prostate cancer in the EU via early detection
PROBASE: digital rectal examination fails to detect early prostate cancer
Advanced prostate cancer: AUA/SUO Guideline
MAGNITUDE: PARP inhibition beneficial in HRR deficient mCRPC
Metastasis-directed therapy delays oligometastatic disease progression
MIRAGE finds that MRI-guided radiotherapy reduces side effects
Vaccine-based immunotherapy trial terminated
Smoking linked to higher risk of death in prostate cancer
Sipuleucel-T can be combined with ARTAs
Neoadjuvant enoblituzumab promising for localised disease
COVID-19 resources
Conferences, Workshops & CPD
Please login below to download this issue (PDF)